490 related articles for article (PubMed ID: 31136747)
1. Development of calcific aortic valve disease: Do we know enough for new clinical trials?
Kostyunin AE; Yuzhalin AE; Ovcharenko EA; Kutikhin AG
J Mol Cell Cardiol; 2019 Jul; 132():189-209. PubMed ID: 31136747
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
[TBL] [Abstract][Full Text] [Related]
3. Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification.
Choi B; Kim EY; Kim JE; Oh S; Park SO; Kim SM; Choi H; Song JK; Chang EJ
Cells; 2021 Jan; 10(1):. PubMed ID: 33401457
[TBL] [Abstract][Full Text] [Related]
4. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.
Hjortnaes J; Goettsch C; Hutcheson JD; Camci-Unal G; Lax L; Scherer K; Body S; Schoen FJ; Kluin J; Khademhosseini A; Aikawa E
J Mol Cell Cardiol; 2016 May; 94():13-20. PubMed ID: 26996755
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells.
Choi B; Lee S; Kim SM; Lee EJ; Lee SR; Kim DH; Jang JY; Kang SW; Lee KU; Chang EJ; Song JK
Circulation; 2017 May; 135(20):1935-1950. PubMed ID: 28179397
[TBL] [Abstract][Full Text] [Related]
6. Sex-related differences in matrix remodeling and early osteogenic markers in aortic valvular interstitial cells.
Masjedi S; Lei Y; Patel J; Ferdous Z
Heart Vessels; 2017 Feb; 32(2):217-228. PubMed ID: 27761653
[TBL] [Abstract][Full Text] [Related]
7. Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor.
Mahmut A; Boulanger MC; Bouchareb R; Hadji F; Mathieu P
Cardiovasc Res; 2015 Apr; 106(1):109-20. PubMed ID: 25644539
[TBL] [Abstract][Full Text] [Related]
8. Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells.
Yoon D; Choi B; Kim JE; Kim EY; Chung SH; Min HJ; Sung Y; Chang EJ; Song JK
BMC Med; 2024 Mar; 22(1):122. PubMed ID: 38486246
[TBL] [Abstract][Full Text] [Related]
9. Deletion of calponin 2 attenuates the development of calcific aortic valve disease in ApoE
Plazyo O; Liu R; Moazzem Hossain M; Jin JP
J Mol Cell Cardiol; 2018 Aug; 121():233-241. PubMed ID: 30053524
[TBL] [Abstract][Full Text] [Related]
10. Comparison of calcification potential of valvular interstitial cells isolated from individual aortic valve cusps.
Masjedi S; Amarnath A; Baily KM; Ferdous Z
Cardiovasc Pathol; 2016; 25(3):185-194. PubMed ID: 26874039
[TBL] [Abstract][Full Text] [Related]
11. Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.
Pasipoularides A
J Cardiovasc Transl Res; 2016 Apr; 9(2):102-18. PubMed ID: 26891845
[TBL] [Abstract][Full Text] [Related]
12. Targeting vasoactive peptides for managing calcific aortic valve disease.
Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
[TBL] [Abstract][Full Text] [Related]
13. Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease.
Yutzey KE; Demer LL; Body SC; Huggins GS; Towler DA; Giachelli CM; Hofmann-Bowman MA; Mortlock DP; Rogers MB; Sadeghi MM; Aikawa E
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2387-93. PubMed ID: 25189570
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease.
Cho KI; Sakuma I; Sohn IS; Jo SH; Koh KK
Atherosclerosis; 2018 Oct; 277():60-65. PubMed ID: 30173080
[TBL] [Abstract][Full Text] [Related]
15. The effect of oxLDL on aortic valve calcification via the Wnt/ β-catenin signaling pathway: an important molecular mechanism.
Gao X; Zhang L; Gu G; Wu PH; Jin S; Hu W; Zhan C; Li J; Li Y
J Heart Valve Dis; 2015 Mar; 24(2):190-6. PubMed ID: 26204684
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen sulfide as an anti-calcification stratagem in human aortic valve: Altered biogenesis and mitochondrial metabolism of H
Combi Z; Potor L; Nagy P; Sikura KÉ; Ditrói T; Jurányi EP; Galambos K; Szerafin T; Gergely P; Whiteman M; Torregrossa R; Ding Y; Beke L; Hendrik Z; Méhes G; Balla G; Balla J
Redox Biol; 2023 Apr; 60():102629. PubMed ID: 36780769
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PP2A enhances the osteogenic differentiation of human aortic valvular interstitial cells via ERK and p38 MAPK pathways.
Xie F; Li F; Li R; Liu Z; Shi J; Zhang C; Dong N
Life Sci; 2020 Sep; 257():118086. PubMed ID: 32679147
[TBL] [Abstract][Full Text] [Related]
18. The Role of Apoptosis and Oxidative Stress in a Cell Spheroid Model of Calcific Aortic Valve Disease.
Coutts CW; Baldwin AM; Jebeli M; Jolin GE; Mungai RW; Billiar KL
Cells; 2023 Dec; 13(1):. PubMed ID: 38201249
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and valvular endothelial cells in aortic valve calcification.
Shu L; Yuan Z; Li F; Cai Z
Biomed Pharmacother; 2023 Jul; 163():114775. PubMed ID: 37116353
[TBL] [Abstract][Full Text] [Related]
20. Label-free optical biomarkers detect early calcific aortic valve disease in a wild-type mouse model.
Tandon I; Johns S; Woessner A; Perez J; Cross D; Ozkizilcik A; Muldoon TJ; Vallurupalli S; Padala M; Quinn KP; Balachandran K
BMC Cardiovasc Disord; 2020 Dec; 20(1):521. PubMed ID: 33308143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
